143 related articles for article (PubMed ID: 3463416)
1. Transplantability and sensitivity to natural killer cells of aclarubicin-resistant murine lymphoma.
Sugimoto Y; Hirakawa Y; Tanaka N; Tahara M; Sato I; Nishimura T; Suzuki H; Tanaka N
Cancer Res; 1986 Nov; 46(11):5646-8. PubMed ID: 3463416
[TBL] [Abstract][Full Text] [Related]
2. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
Tanaka N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
[TBL] [Abstract][Full Text] [Related]
3. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
Schultz RM; Tang JC; DeLong DC; Ades EW; Altom MG
Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909
[TBL] [Abstract][Full Text] [Related]
4. Murine natural antitumor antibodies. III. Interferon treatment of a natural killer-resistant lymphoma: augmentation of natural antibody reactivity and susceptibility to in vivo natural resistance.
Miller VE; Pohajdak B; Greenberg AH
J Natl Cancer Inst; 1983 Aug; 71(2):377-84. PubMed ID: 6576195
[TBL] [Abstract][Full Text] [Related]
5. Selective depletion of NK cell activity in vivo and its effect on the growth of NK-sensitive and NK-resistant tumor cell variants.
Kawase I; Urdal DL; Brooks CG; Henney CS
Int J Cancer; 1982 May; 29(5):567-74. PubMed ID: 7095901
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
Li LH; Wallace TL; Richard KA; Tracey DE
Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
[TBL] [Abstract][Full Text] [Related]
7. Tumor selection in vivo for reduced sensitivity to natural resistance and natural antibodies.
Chow DA
J Natl Cancer Inst; 1984 Feb; 72(2):339-46. PubMed ID: 6582320
[TBL] [Abstract][Full Text] [Related]
8. Discrimination between macrophage-and NK-type tumoricidal activities via anti-asialo GM1 antibody.
Keller R; Bächi T; Okumura K
Exp Cell Biol; 1983; 51(3):158-64. PubMed ID: 6852344
[TBL] [Abstract][Full Text] [Related]
9. [In vitro cytolysis mediated by NK effectors: modification of the susceptibility of the target cell by in vivo treatment with DTIC].
Migliorati G; Romani L; Fioretti MC
Boll Soc Ital Biol Sper; 1981 May; 57(9):1024-30. PubMed ID: 7284118
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of augmentation of natural killer cell activity by syngeneic tumor cells: role of macrophage-derived factor in NK boosting.
Kawase I; Urdal DL; Newman W; Henney CS
Int J Cancer; 1983 Mar; 31(3):365-72. PubMed ID: 6402456
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of action and resistance of antineoplastic agents].
Tanaka N
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2245-51. PubMed ID: 6195971
[TBL] [Abstract][Full Text] [Related]
12. Role of natural killer cells against tumor growth in nude mice--a brief review.
Habu S; Fukui H; Shimamura K; Kasai M; Okumura K; Tamaoki N
Tokai J Exp Clin Med; 1983 Dec; 8(5-6):465-8. PubMed ID: 6681342
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic alterations in tumors that developed from threshold subcutaneous inocula. I. Reduced binding of natural antibodies and sensitivity to hypotonic lysis.
Brown GW; Lesiuk TP; Chow DA
J Immunol; 1986 Apr; 136(8):3116-23. PubMed ID: 3958491
[TBL] [Abstract][Full Text] [Related]
14. Reduction of acute graft-versus-host disease-related mortality and cytotoxic T lymphocyte induction after pretreatment of the recipient with anti-asialo GM1 antibody in the murine P-to-F1 model.
Varkila K; Hurme M
Transplant Proc; 1987 Feb; 19(1 Pt 3):2690-1. PubMed ID: 3274580
[No Abstract] [Full Text] [Related]
15. Suppression of pulmonary tumour metastasis in mice by recombinant human interleukin-2: role of asialo GM1-positive cells.
Hinuma S; Naruo K; Ootsu K; Houkan T; Shiho O; Tsukamoto K
Immunology; 1987 Feb; 60(2):173-9. PubMed ID: 3493209
[TBL] [Abstract][Full Text] [Related]
16. [Comparative analysis of the sensitivity to natural killers and macrophages of 3-methylcholanthrene-induced tumors in mice].
Viksler VKh; Iaroslavtseva OA; Lavroskiĭ VA
Eksp Onkol; 1986; 8(6):36-40. PubMed ID: 3803287
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
Gorelik E
Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
[TBL] [Abstract][Full Text] [Related]
19. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
[TBL] [Abstract][Full Text] [Related]
20. [Role of asialo GM 1 positive cells in the control of metastatic spread of tumor cells in mice].
Shibuya M; Saijo N; Ozaki A; Beppu Y; Shimizu E; Takizawa T; Hoshi A
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1781-6. PubMed ID: 6882003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]